Pharmacotherapy for Patients with Advanced and Metastatic Prostate Cancer

Presenter: Dr. Andrew Feifer
Original Date: Tuesday, June 26, 2018

Description:
This webinar is an introduction to common drug treatments available for advanced and metastatic prostate cancer. Dr. Andrew Feifer discusses the role of testosterone and the androgen receptor in the development and growth of prostate cancer. Further, Dr. Feifer will discuss the efficacy and side effects of these drug based treatments including hormone therapy and novel therapies for castration resistant prostate cancer.

 
Download or order our B brochure and Advanced Prostate Cancer brochure.
 
 
 

Andrew FeiferAndrew Feifer's Biography:

Dr. Andrew Feifer is a urologic oncologist at the Carlo Fidani Cancer Centre at Credit Valley Hospital where he specializes in the management of advanced castrate resistant prostate cancer. He is also an assistant professor of surgery at the University of Toronto and a faculty member at Princess Margaret University Health Network. Dr. Feifer maintains active research interest in urologic oncology outcomes, quality of care in surgery, and comparative effectiveness of new surgical techniques.

About Expert Angle

Expert Angle is designed to expand our reach and address the many varied and complex questions that come with a prostate cancer diagnosis. These webinars will address topics important to men with prostate cancer along different points of the cancer care continuum and those within their circle of care as well as the general public and representatives from the clinical community.
 
The meetings are hosted using interactive on-line technology and feature leading experts in prostate cancer - making them accessible to anyone, regardless of their location, within Canada. The platform allows PCC to communicate directly with individuals in a variety of settings (i.e. in their homes, support group meetings, community centres) and geographic locations (i.e. urban, rural and remote locations) as well as measure engagement.   

View more Expert Angle webinars.

   








Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
1.5 million Canadian men over 50 now at unnecessary risk for prostate cancer

Toronto (ON) – September 26, 2019 – New findings released today in a Prostate Cancer Canada nationwide survey suggest 1.
More

$2 million invested in new prostate cancer research

Prostate Cancer Canada and Movember partner to fund ten research projects breaking new ground
More

Dream car draw a win for all Ontarians affected by prostate cancer

February 22, 2019 – TORONTO, ON – A dream came true today for Harold Mutter (ticket #19273), the lucky winner of a 2018 Acura NSX valued at more than $235,000 - the prize for Prostate Cancer Canada’s seventh Rock the Road Raffle.
More

Researchers discover common markers of tumour hypoxia across 19 cancer types

Landmark pan-cancer study analyzes mutation signatures of low oxygen in more than 8,000 tumours
More

Rock the Road Raffle returns with its most valuable car to date

A 2018 Acura NSX to be prized by Prostate Cancer Canada and TADA at the AutoShow  
More


Click here for news archive